Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Tauhid Ali
VP and Head at Takeda TAK-celerator

Profile

Tauhid Ali serves as Vice President, Head Takeda TAK-celerator, a group focused on accelerating transformative therapies for people with rare diseases or indications where there remains a significant unmet need. The TAK-celerator is part of Takeda’s Center for External Innovation (CEI) organization, adopting an incubator-like model to develop and externalise effective therapies. Its mission is to move assets through translation into novel therapies whereby externalisation paths, such as creation of new companies or collaborations with external partners, are made possible to increase the chances of reaching more patients. The TAK-celerator operates a very lean and entrepreneurial model primarily utilising external services and leveraging an extensive knowledge-based network.

With more than 20 years international experience in the biopharmaceutical industry, Tauhid has broad management and leadership experience in translational research, corporate strategy, global development and global project leadership. His work encompasses development of both small molecules and antibody therapeutics within a broad range of therapeutic areas, including oncology, autoimmune/inflammatory diseases, as well as orphan diseases.

Tauhid has a Ph.D. from Cardiff University and a MSc in Clinical Sciences from the Welsh School of Pharmacy.

Tauhid Ali's Network

Agenda Sessions

  • The shifting model: How new era, patient-led collaborations are transforming drug discovery and development in rare disease, and beyond - Hilton Union Square

    ,